Prostate Diffusion Imaging With Distortion Correction

NCT06185478 — Not applicable, Withdrawn, Norfolk and Norwich University Hospitals NHS Foundation Trust

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT06185478
StatusWithdrawn - Study abandoned due to COVID-19 (07/06/2024).
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, diagnostic
SponsorNorfolk and Norwich University Hospitals NHS Foundation Trust (Other); collaborators: University of East Anglia
ConditionsProstate Cancer
InterventionsMRI scan (Diagnostic test)
Datesstart 2024-03-01 (estimated), primary completion 2027-01-01 (estimated), completion 2027-01-01 (estimated), first posted 2023-12-29, last updated 2026-06-08
Locations1 site in United Kingdom

Related Papers Related Patents Related Grants Related Experts
All trials for Prostate Cancer All trials of MRI scan

-Summary

There has been literature demonstrating the effectiveness of correcting these MRI images by using an additional measurement of the magnetic field, but the implied improvement in lesion detection in these common distorted regions in the prostate has yet to be shown.

We propose that introducing this distortion correction would greatly improve the DWI images used for tumour detection. For this study we propose testing this hypothesis as a primary objective, and as a secondary objective including additional b-values to further refine the ADC value. The study involves adding one additional distortion correcting scan to the standard clinical study, adding approximately 2 minutes to the study.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
ImagingExperimentalDiagnostic Test: MRI scan
  • MRI scan (Diagnostic test): MRI scan

+Outcome measures

Primary outcomes

  • MRI image quality [12 months]: To determine whether correcting for the distortion in MRI images caused by rectal gas improves the image quality and thus diagnostic ability in localising and detecting prostate cancer

+Eligibility

Sex: Male, ages: 18 Years to 100 Years

Inclusion Criteria:

* Male
* Aged 18 and over
* No contraindication to MR scanning
* Smokers and non-smokers
* Patients who have had a complete scan on the 3T scan MRI at Norfolk and Norwich University Hospital and have gone on to have a biopsy at the Norfolk and Norwich University Hospital

Exclusion Criteria:

* Previous diagnosis of prostate cancer, prostatic biopsy or treatment for prostate cancer

+Locations (1)

FacilityCityCountryStatus
Norfolk and Norwich University Hospitals NHS Foundation TrustNorwich, NorfolkUnited Kingdom

+Investigators

  • Paul Malcolm, Principal investigator, Norfolk and Norwich University Hospitals NHS Foundation Trust